KorrekturOpen Access · CC BY 4.0
Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”
Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)
DOI: 10.1155/omcl/9783010 ↗Kurz gefasst
Korrektur in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 01.03.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9783010
Vancouver
Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9783010
BibTeX
@article{euvimed2026,
title = {Correction to “Corynoline Alleviates Osteoarthritis Development via the Nrf2/NF‐κB Pathway”},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/omcl/9783010}
}
EUVIMED